Exopharm Limited (ASX:EX1)
Exopharm Limited is an Australia-based clinical-stage biopharmaceutical company that operates in the healthcare sector. The Company is focused on developing and commercializing exosomes as therapeutic agents. The Company has three technologies that allows customization of exosomes, in which the LOAD technology improves loading of nucleic medicines into exosomes and the EVPS technology allows exosomes to be directed towards selected cell types. Its LEAP manufacturing technology provides access to exosomes for research and clinical uses. The Company is developing Engineered EVs (EEVs), are an emerging form of precision medicine with application in areas, such as neurology, cardiology and oncology. Its EEV projects under development are Fortrexo, Cognevo and PlexoDOX.